Literature DB >> 2163768

A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro.

H Ge1, J L Manley.   

Abstract

SV40 early pre-mRNA is alternatively spliced by utilization of two different 5' splice sites and a shared 3' splice site to produce large T and small t mRNAs. The ratio of small t to large T mRNAs produced in human embryonic kidney 293 cells is 10- to 20-fold greater than in other mammalian cells, suggesting the existence of a 293 cell-specific factor that modulates alternative splicing. Here we show that nuclear extracts from 293 cells give rise to significantly more small t splicing than do extracts from HeLa cells. Using an in vitro complementation assay, we have characterized and extensively purified a factor from 293 extracts that brings about striking increases in small t splicing with concomitant decreases in large T splicing. The factor is heat sensitive and micrococcal nuclease resistant, suggesting that it is a protein lacking an accessible RNA component. Purification of the alternative splicing factor indicates that the activity is contained in one of several possibly related polypeptides of 30-35 kd.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163768     DOI: 10.1016/0092-8674(90)90236-8

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  203 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers.

Authors:  R C Dietrich; G C Shukla; J D Fuller; R A Padgett
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

5.  Kinetic analysis of the steps of the polyomavirus lytic cycle.

Authors:  L Chen; M Fluck
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 6.  RNA-protein interactions that regulate pre-mRNA splicing.

Authors:  Ravinder Singh
Journal:  Gene Expr       Date:  2002

Review 7.  Sorting out the complexity of SR protein functions.

Authors:  B R Graveley
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

8.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

9.  Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors.

Authors:  E Birney; S Kumar; A R Krainer
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

10.  Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice.

Authors:  F Yull; G Harold; R Wallace; A Cowper; J Percy; I Cottingham; A J Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.